Pharmacologic vitreodynamics

International Ophthalmology Clinics

Volumn 49, Issue 2, 2009, Pages 135-140

  Ranchod, Tushar M ^a   Goldenberg, David T ^a   Trese, Michael T ^a  

^a ASSOCIATED RETINAL CONSULTANTS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISPASE; FIBRONECTIN; HYALURONIDASE; LAMININ; N ACETYLGALACTOSAMINE 4 SULFATASE; PLASMIN; SUBTILISIN; HYALURONOGLUCOSAMINIDASE; NATTOKINASE;

CLINICAL TRIAL; DIABETIC RETINOPATHY; DRUG EFFECT; DRUG MECHANISM; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; VITRECTOMY; VITREOUS BODY; VITREOUS BODY DETACHMENT; ANIMAL; METABOLISM; PATHOLOGY; SOYBEAN; TREATMENT OUTCOME; VITREOUS HEMORRHAGE;

ANIMALS; DIABETIC RETINOPATHY; HUMANS; HYALURONOGLUCOSAMINIDASE; SOY FOODS; SUBTILISINS; TREATMENT OUTCOME; VITRECTOMY; VITREOUS BODY; VITREOUS HEMORRHAGE;

EID: 67650258223     PISSN: 00208167     EISSN: None     Source Type: Journal    
DOI: 10.1097/IIO.0b013e31819fd66b     Document Type: Review

References (32)

1. Sebag J. Macromolecular structure of vitreous. Prog Polym Sci. 1998;23:415-446.
2. Sebag J. Molecular biology of pharmacologic vitreolysis. Trans Am Ophthalmol Soc. 2005;103:473-494.
3. Wang F, Wang Z, Sun X, et al. Safety and efficacy of dispase and plasmin in pharmacologic vitreolysis. Invest Ophthalmol Vis Sci. 2004;45:3286-3290. (Pubitemid 39121868)
4. Zhu D, Chen H, Xu X. Effects of intravitreal dispase on vitreoretinal interface in rabbits. Curr Eye Res. 2006;31:935-946. (Pubitemid 44777371)
5. Jorge R, Oyamaguchi EK, Cardillo JA, et al. Intravitreal injection of dispase causes retinal hemorrhages in rabbit and human eyes. Curr Eye Res. 2003;26:107-112. (Pubitemid 36776117)
6. Bishop PN, McLeod D, Reardon A. Effects of hyaluronan lyase, hyaluronidase, and chondroitin ABC lyase on mammalian vitreous gel. Invest Ophthalmol Vis Sci. 1999;40:2173-2178. (Pubitemid 29418369)
7. Hermel M, Schrage NF. Efficacy of plasmin enzymes and chondroitinase ABC in creating posterior vitreous separation in the pig: a masked, placebo-controlled in vivo study. Graefes Arch Clin Exp Ophthalmol. 2007;245:399-406. (Pubitemid 46404001)
8. Kuppermann BD, Thomas EL, de Smet MD, et al. Pooled efficacy results from two multinational randomized controlled clinical trials of a single intravitreous injection of highly purified ovine hyaluronidase (Vitrase) for the management of vitreous hemorrhage. Am J Ophthalmol. 2005;140:573-584. (Pubitemid 41455296)
9. Hikichi T, Kado M, Yoshida A. Intravitreal injection of hyaluronidase cannot induce posterior vitreous detachment in the rabbit. Retina. 2000;20:195-198. (Pubitemid 30395716)
10. Quiram PA, Leverenz VR, Baker RM, et al. Microplasmin-induced posterior vitreous detachment affects vitreous oxygen levels. Retina. 2007;27:1090-1096.
11. Wang ZL, Zhang X, Xu X, et al. PVD following plasmin but not hyaluronidase: implications for combination pharmacologic vitreolysis therapy. Retina. 2005;25:38-43. (Pubitemid 40250406)
12. Sumi H, Hamada H, Tsushima H, et al. A novel fibrinolytic enzyme (nattokinase) in the vegetable cheese Natto; a typical and popular soybean food in the Japanese diet. Experientia. 1987;43:1110-1111.
13. Takano A, Hirata A, Ogasawara K, et al. Posterior vitreous detachment induced by nattokinase (subtilisin NAT): a novel enzyme for pharmacologic vitreolysis. Invest Ophthalmol Vis Sci. 2006;47:2075-2079. (Pubitemid 46768291)
14. Urano T, Ihara H, Umemura K, et al. The profibrinolytic enzyme subtilisin NAT purified from Bacillus subtilis Cleaves and inactivates plasminogen activator inhibitor type 1. J Biol Chem. 2001;276:24690-24696. (Pubitemid 37412937)
15. Kohno T, Sorgente N, Ishibashi T, et al. Immunofluorescent studies of fibronectin and laminin in the human eye. Invest Ophthalmol Vis Sci. 1987;28:506-514. (Pubitemid 17040860)
16. Liotta LA, Goldfarb RH, Brundage R, et al. Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane. Cancer Res. 1981;41(11 Pt 1):4629-4636. (Pubitemid 12201384)
17. Uemura A, Nakamura M, Kachi S, et al. Effect of plasmin on laminin and fibronectin during plasmin-assisted vitrectomy. Arch Ophthalmol. 2005;123:209-213. (Pubitemid 40189708)
18. Gandorfer A, Putz E, Welge-Lussen U, et al. Ultrastructure of the vitreoretinal interface following plasmin assisted vitrectomy. Br J Ophthalmol. 2001;85:6-10. (Pubitemid 32060187)
19. Asami T, Terasaki H, Kachi S, et al. Ultrastructure of internal limiting membrane removed during plasmin-assisted vitrectomy from eyes with diabetic macular edema. Ophthalmology. 2004;111:231-237. (Pubitemid 38183220)
20. Azzolini C, D'Angelo A, Maestranzi G, et al. Intrasurgical plasmin enzyme in diabetic macular edema. Am J Ophthalmol. 2004;138:560-566. (Pubitemid 39420482)
21. Margherio AR, Margherio RR, Hartzer M, et al. Plasmin enzyme-assisted vitrectomy in traumatic pediatric macular holes. Ophthalmology. 1998;105:1617-1620. (Pubitemid 28513509)
22. Williams JG, Trese MT, Williams GA, et al. Autologous plasmin enzyme in the surgical management of diabetic retinopathy. Ophthalmology. 2001;108:1902-1905; discussion 1905-1906.
23. Trese MT, Williams GA, Hartzer MK. A new approach to stage 3 macular holes. Ophthalmology. 2000;107:1607-1611.
24. Nagai N, Demarsin E, Van Hoef B, et al. Recombinant human microplasmin: production and potential therapeutic properties. J Thromb Haemost. 2003;1:307-313.
25. Gandorfer A, Rohleder M, Sethi C, et al. Posterior vitreous detachment induced by microplasmin. Invest Ophthalmol Vis Sci. 2004;45:641-647. (Pubitemid 38140525)
26. Goldenberg DT, Leverenz VR, Giblin FJ, et al. Posterior vitreous detachment alters retinal penetration of intravitreal bevacizumab (Avastin) in rabbit eyes. Invest Ophthalmol Vis Sci. 2008;49. ARVO E-Abstract 5616.
27. Patel JI, Tombran-Tink J, Hykin PG, et al. Vitreous and aqueous concentrations of proangiogenic, antiangiogenic factors and other cytokines in diabetic retinopathy patients with macular edema: Implications for structural differences in macular profiles. Exp Eye Res. 2006;82:798-806. (Pubitemid 43170880)
28. Holekamp NM, Shui YB, Beebe DC. Vitrectomy surgery increases oxygen exposure to the lens: a possible mechanism for nuclear cataract formation. Am J Ophthalmol. 2005;139:302-310.
29. Stefansson E, Novack RL, Hatchell DL. Vitrectomy prevents retinal hypoxia in branch retinal vein occlusion. Invest Ophthalmol Vis Sci. 1990;31:284-289. (Pubitemid 20072693)
30. Kamei M, Misono K, Lewis H. A study of the ability of tissue plasminogen activator to diffuse into the subretinal space after intravitreal injection in rabbits. Am J Ophthalmol. 1999;128:739-746. (Pubitemid 30001770)
31. Stefansson E. Ocular oxygenation and the treatment of diabetic retinopathy. Surv Ophthalmol. 2006;51:364-380. (Pubitemid 43970734)
32. Stefansson E. Microplasmin-induced posterior vitreous detachment affects vitreous oxygen levels. Retina. 2008;28:1175-1176.